$1.90
5.00% yesterday
Nasdaq, Aug 11, 10:00 pm CET

ImmunoPrecise Antibodies Ltd Stock price

$1.90
+0.42 28.38% 1M
+1.44 312.06% 6M
+1.49 361.50% YTD
+1.31 219.87% 1Y
-3.35 63.81% 3Y
-3.39 64.10% 5Y
+1.80 1,709.52% 10Y
+1.71 900.00% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-0.10 5.00%

Key metrics

Basic
Market capitalization
$92.3m
Enterprise Value
$92.3m
Net debt
$10.0k
Cash
$9.4m
Shares outstanding
45.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
5.3 | 4.9
EV/Sales
5.3 | 4.9
EV/FCF
negative
P/B
5.1
Financial Health
Equity Ratio
56.6%
Return on Equity
-80.1%
ROCE
-39.5%
ROIC
-51.3%
Debt/Equity
0.5
Financials (TTM | estimate)
Revenue
$17.4m | $18.7m
EBITDA
$-8.6m | -
EBIT
$-10.5m | $-9.5m
Net Income
$-33.5m | $-21.2m
Free Cash Flow
$-6.9m
Growth (TTM | estimate)
Revenue
1.3% | 4.7%
EBITDA
8.9% | -
EBIT
13.2% | 7.3%
Net Income
-223.3% | -7.2%
Free Cash Flow
-107.2%
Margin (TTM | estimate)
Gross
50.8%
EBITDA
-49.6% | -
EBIT
-60.2%
Net
-192.2% | -113.5%
Free Cash Flow
-39.5%
More
EPS
$-1.0
FCF per Share
$-0.2
Short interest
1.1%
Employees
87
Rev per Employee
$200.0k
Show more

Is ImmunoPrecise Antibodies Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

ImmunoPrecise Antibodies Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a ImmunoPrecise Antibodies Ltd forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a ImmunoPrecise Antibodies Ltd forecast:

Buy
83%
Hold
17%

Financial data from ImmunoPrecise Antibodies Ltd

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jan '25
+/-
%
17 17
1% 1%
100%
- Direct Costs 8.56 8.56
4% 4%
49%
8.85 8.85
1% 1%
51%
- Selling and Administrative Expenses 14 14
11% 11%
81%
- Research and Development Expense 3.47 3.47
32% 32%
20%
-8.64 -8.64
9% 9%
-50%
- Depreciation and Amortization 1.85 1.85
29% 29%
11%
EBIT (Operating Income) EBIT -10 -10
13% 13%
-60%
Net Profit -33 -33
223% 223%
-192%

In millions USD.

Don't miss a Thing! We will send you all news about ImmunoPrecise Antibodies Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ImmunoPrecise Antibodies Ltd Stock News

Neutral
Business Wire
6 days ago
AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a biotherapeutics company delivering advanced solutions in biologics and drug discovery, today announced the successful sale of its Netherlands-based subsidiary, ImmunoPrecise Antibodies (Europe) B.V. (“IPA Europe”), to AVS Bio for a total enterprise value of $12 million USD. AVS B...
Neutral
Business Wire
6 days ago
WASHINGTON & NORWICH, Conn.--(BUSINESS WIRE)--Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced that its portfolio company AVS Bio, a leading global provider of critical inputs and services for the bioprocessing and biologics industries, acquired ImmunoPrecise Antibodies (Europe) B.V. (“IPA ...
Neutral
The Motley Fool
7 days ago
Image source: The Motley Fool.
More ImmunoPrecise Antibodies Ltd News

Company Profile

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.

Head office Canada
CEO Jennifer Bath
Employees 87
Founded 1983
Website www.ipatherapeutics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today